Moderna, Inc. (MUN:0QF)

Moderna Statistics

Total Valuation

Moderna has a market cap or net worth of EUR 8.06 billion. The enterprise value is 2.92 billion.

Market Cap	8.06B
Enterprise Value	2.92B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	390.73M
Shares Outstanding	n/a
Shares Change (YoY)	+1.31%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	6.52%
Owned by Institutions (%)	71.88%
Float	364.94M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.24
PB Ratio	1.01
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-1.10
EV / Sales	1.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.29

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.08.

Current Ratio	3.93
Quick Ratio	3.51
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	-0.28
Interest Coverage	-432.88

Financial Efficiency

Return on equity (ROE) is -29.32% and return on invested capital (ROIC) is -18.54%.

Return on Equity (ROE)	-29.32%
Return on Assets (ROA)	-15.49%
Return on Invested Capital (ROIC)	-18.54%
Return on Capital Employed (ROCE)	-33.13%
Revenue Per Employee	327,989
Profits Per Employee	-457,891
Employee Count	5,800
Asset Turnover	0.16
Inventory Turnover	15.39

Taxes

Income Tax	-31.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -48.47% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-48.47%
50-Day Moving Average	23.28
200-Day Moving Average	57.89
Relative Strength Index (RSI)	43.43
Average Volume (20 Days)	114

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.43

Income Statement

In the last 12 months, Moderna had revenue of EUR 1.90 billion and -2.66 billion in losses. Loss per share was -6.86.

Revenue	1.90B
Gross Profit	-2.98B
Operating Income	-2.95B
Pretax Income	-2.69B
Net Income	-2.66B
EBITDA	-2.77B
EBIT	-2.95B
Loss Per Share	-6.86

Balance Sheet

The company has 3.84 billion in cash and 625.59 million in debt, giving a net cash position of 5.04 billion.

Cash & Cash Equivalents	3.84B
Total Debt	625.59M
Net Cash	5.04B
Net Cash Per Share	n/a
Equity (Book Value)	7.95B
Book Value Per Share	20.34
Working Capital	4.19B

Cash Flow

In the last 12 months, operating cash flow was -1.69 billion and capital expenditures -575.30 million, giving a free cash flow of -2.26 billion.

Operating Cash Flow	-1.69B
Capital Expenditures	-575.30M
Free Cash Flow	-2.26B
FCF Per Share	n/a

Margins

Gross margin is -156.54%, with operating and profit margins of -155.15% and -139.61%.

Gross Margin	-156.54%
Operating Margin	-155.15%
Pretax Margin	-141.26%
Profit Margin	-139.61%
EBITDA Margin	-145.83%
EBIT Margin	-155.15%
FCF Margin	n/a

Dividends & Yields

Moderna does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.31%
Shareholder Yield	-1.31%
Earnings Yield	-32.95%
FCF Yield	-28.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Moderna has an Altman Z-Score of 3.5 and a Piotroski F-Score of 1.

Altman Z-Score	3.5
Piotroski F-Score	1